Literature DB >> 8573381

Human herpesvirus 6 variant A, but not variant B, infects EBV-positive B lymphoid cells, activating the latent EBV genome through a BZLF-1-dependent mechanism.

L Cuomo1, A Angeloni, C Zompetta, M Cirone, A Calogero, L Frati, G Ragona, A Faggioni.   

Abstract

Human herpesvirus 6, a predominantly T lymphotropic virus, has been recently shown to infect some EBV-positive B cell lines, and to induce in them the activation of the EBV lytic cycle. Here we have confirmed and extended such observations, showing that (1) this phenomenon is restricted to the variant A of HHV-6: in fact two isolates belonging to the HHV-6 variant B (BA92 and Z29) were neither able to infect any B cell line, independently of the EBV status, nor to induce the EBV genome expression. The only exception is represented by the P3HR1 cells, in which, however, the infection by the variant B does not determine induction of EBV antigens; (2) the presence of the EBV genome contributes to the susceptibility of the B cell lines to HHV-6 infection, increasing the binding sites and the percentage of infectable cells, as detected by immunoelectron microscopy; and (3) HHV-6 infected T cells, transfected with plasmids bearing the promoter regions of the EBV early genes BZLF1 and BMRF1, show a strong transactivation of these promoters.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8573381     DOI: 10.1089/aid.1995.11.1241

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  11 in total

1.  Viral glycoproteins accumulate in newly formed annulate lamellae following infection of lymphoid cells by human herpesvirus 6.

Authors:  G Cardinali; M Gentile; M Cirone; C Zompetta; L Frati; A Faggioni; M R Torrisi
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

2.  The Epstein-Barr virus and systemic lupus erythematosus.

Authors:  J H Vaughan
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

Review 3.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.

Authors:  Dongsheng Xu; Tricia Coleman; Jun Zhang; Ashley Fagot; Catherine Kotalik; Lingjun Zhao; Pankaj Trivedi; Clinton Jones; Luwen Zhang
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Detection and typing of human herpesvirus 6 by molecular methods in specimens from patients diagnosed with encephalitis or meningitis.

Authors:  Norma P Tavakoli; Seela Nattanmai; Rene Hull; Heather Fusco; Lela Dzigua; Heng Wang; Michelle Dupuis
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

Review 6.  Multiple sclerosis: an example of pathogenic viral interaction?

Authors:  Walter Fierz
Journal:  Virol J       Date:  2017-02-28       Impact factor: 4.099

Review 7.  Human Herpesvirus 6 and Malignancy: A Review.

Authors:  Eva Eliassen; Emily Lum; Joshua Pritchett; Joseph Ongradi; Gerhard Krueger; John R Crawford; Tuan L Phan; Dharam Ablashi; Stanley David Hudnall
Journal:  Front Oncol       Date:  2018-11-13       Impact factor: 6.244

8.  Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.

Authors:  Elin Engdahl; Rasmus Gustafsson; Jesse Huang; Martin Biström; Izaura Lima Bomfim; Pernilla Stridh; Mohsen Khademi; Nicole Brenner; Julia Butt; Angelika Michel; Daniel Jons; Maria Hortlund; Lucia Alonso-Magdalena; Anna Karin Hedström; Louis Flamand; Masaru Ihira; Tetsushi Yoshikawa; Oluf Andersen; Jan Hillert; Lars Alfredsson; Tim Waterboer; Peter Sundström; Tomas Olsson; Ingrid Kockum; Anna Fogdell-Hahn
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

Review 9.  Environmental Influencers, MicroRNA, and Multiple Sclerosis.

Authors:  Eiman Ma Mohammed
Journal:  J Cent Nerv Syst Dis       Date:  2020-01-20

10.  Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.

Authors:  Ute-Christiane Meier; Richard Christopher Cipian; Abbas Karimi; Ranjan Ramasamy; Jaap Michiel Middeldorp
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.